Medications dose individualisation software developer DoseMe is set to invest in commercialising the product in Australia and integrating it with electronic medical records as it prepares for entry into the US and European markets, following the successful closure of a $2.6 million Series A financing round.

Brisbane-based DoseMe, which was established in 2014 with seed funding from private investor Steve Baxter, is now valued at $20 million after it secured further funding from two local investors, Greg Spurgin and Gary Cunningham, who together co-founded an outpatient orthopaedic physical therapy company called Results Physiotherapy that has proved successful in the US.